Re: Share Capital

RNS Number:1209O
Celsis International PLC
28 June 2005

28 June 2005


                            Celsis International plc
                          ("Celsis" or the "Company")

                    Proposed Consolidation of Share Capital


Celsis International plc, the microbial contamination and analytical services
group, today announces that at the Company's Annual General Meeting to be held
on 26 July 2005, shareholders will be asked to consider and pass a resolution to
consolidate the existing ordinary shares of 1p each on the basis of one new
ordinary share of 5p each for every five existing ordinary shares (the 
"Consolidation").  Further details of the proposed Consolidation are contained 
in the Directors' report section of the Report and Accounts, which is being 
posted to shareholders today.

The Directors believe that the current price at which the Company's shares are
traded is a barrier to attracting new investors, especially in the US, and the
ability of the Company to make acquisitions for shares should it wish to do so.
As one example, the US NASDAQ Stock Market will in certain circumstances de-list
a company's shares if they trade below $1.00 for more than a certain period. The
Directors also believe that the Consolidation should lead to a reduction in the
bid-offer spread and an improvement in the liquidity of the Company's shares.

Shareholders with a holding which is not exactly divisible by five will, in
accordance with the discretion given in Article 8 of the Company's articles of
association, have their holding rounded down to the nearest whole number of new
ordinary shares following the Consolidation.  Fractional entitlements will be
sold in the market and the proceeds will be retained for the benefit of the
Company.

Application will be made to the UKLA for the cancellation of the existing
ordinary shares and admission of the new ordinary shares (i) to the Official
List in accordance with the Listing Rules issued by the UK Listing Authority,
and (ii) to trading on the London Stock Exchange's market for listed securities.
Admission of the new ordinary shares is expected to become effective on
Tuesday, 30 August 2005.

Jay LeCoque, CEO of Celsis, commented: "We believe the proposed consolidation
being announced today should assist in improving the attractiveness and
liquidity of Celsis shares, through a combination of an increased price per
share and a reduction in the bid / offer spread."


Enquires:

Celsis International plc                                 Tel: [phone]
Jay LeCoque, Chief Executive Officer
Christian Madrolle, Finance Director

Financial Dynamics                                       Tel: [phone]
David Yates / Lucy Briggs


Celsis International plc

Celsis International plc is a microbial detection and analytical services
company operating through two divisions, the Product Group and the Laboratory
Group.

Using its proprietary enzyme technology, the Product Group is the world leader
in the provision of diagnostic systems for the rapid detection of microbial
contamination.  It works in close collaboration with many of the world's leading
pharmaceutical, personal care and beverage companies, ensuring the safety and
quality of products bound for consumers.  The Laboratory Group provides
outsourced analytical testing services to pharmaceutical companies to ensure the
stability and chemical composition of their products.

In addition to ensuring product quality and safety for consumers, both divisions
have the capacity to deliver substantial cost savings to Celsis' customers.  By
reducing the time it takes to test and release raw materials and finished goods
to the market place, Celsis' products facilitate increased manufacturing
productivity and improved supply chain management.

Celsis International plc is listed on the London Stock Exchange (CEL.L).
Further information can be found on the Company's website at www.celsis.com.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

CARMGGZVRNLGKZM